Left Ventricular Global Longitudinal Strain Is Associated With Appropriate Therapies for Ventricular Arrhythmias Independent of Left Ventricular Ejection Fraction in Patients With Primary Prevention Defibrillators
Open Access
- 24 May 2026
- journal article
- research article
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3) , e70376
Abstract
Background: Left ventricular ejection fraction (LVEF) has not demonstrated reliability in predicting ventricular arrhythmias or appropriate implantable cardioverter defibrillator (ICD) therapy (AICDt). Objective: To evaluate the association between left ventricular global longitudinal strain (GLS) and AICDt. Methods: One hundred seventy‐eight consecutive patients who received ICD implants for primary prevention of sudden cardiac death from 1/16/2015 to 1/26/2022 were followed until 1st appropriate ICD therapy (AICDt) for a ventricular arrhythmia, death, or loss to follow‐up. AICDt were physician adjudicated. Covariates included demographic variables (age, sex), clinical risk factors (LVEF, cardiac resynchronization therapy, coronary artery disease, anti‐arrhythmic drug use, QRS duration), and variables from the DO‐IT model (nonsustained ventricular tachycardia, atrial fibrillation, glomerular filtration rate, peripheral vascular disease, direct oral anticoagulant use, digoxin use, aldosterone antagonist use, and angiotensin converting enzyme inhibitor/angiotensin II receptor blocker use). Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI 95 ) of GLS per 5% decrease (absolute value) for AICDt. Results: Over a mean (standard deviation) follow up period of 5.09 (2.11) years, 44 of the 178 patients (79.77% male, 63.89 (12.89) years of age) in the final cohort experienced AICDt. In patients with coronary artery disease, GLS per 5% decrease (absolute value) was associated with AICDt independent of demographic variables (HR 2.16, CI 95 1.09–4.27), clinical risk factors (HR 2.54, CI 95 1.16–5.59), and variables from the DO‐IT model (HR 3.28, CI 95 1.46–7.36). Conclusion: Reduced GLS (absolute value) is an independent risk factor for AICDt in patients with coronary artery disease.Keywords
This publication has 10 references indexed in Scilit:
- Myocardial Strain ImagingJACC: Cardiovascular Imaging, 2024
- Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillatorJournal of Interventional Cardiac Electrophysiology, 2024
- Strain Imaging and Ventricular ArrhythmiaDiagnostics, 2023
- Strain by speckle tracking echocardiography correlates with electroanatomic scar location and burden in ischaemic cardiomyopathyEuropean Heart Journal - Cardiovascular Imaging, 2021
- Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac deathEP Europace, 2021
- Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fractionJournal of Cardiovascular Medicine, 2020
- Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic trainingCardiovascular Ultrasound, 2019
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac DeathJACC, 2018
- Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart FailureJACC, 2018
- Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different VendorsJournal of the American Society of Echocardiography, 2015